Brittany Kinsler, CNS in Jber, AK - Clinical Nurse Specialist

Brittany Kinsler, CNS is a Clinical Nurse Specialist - Acute Care based in Jber, Alaska. Brittany Kinsler is licensed to practice in Tennessee (license number 30615) and her current practice location is 5955 Zeamer Ave, Jber, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 580-5556.

NPI number for Brittany Kinsler is 1992428288 and her current mailing address is 5955 Zeamer Ave, Jber, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1992428288.

Contact Information

	Brittany Kinsler, CNS
	5955 Zeamer Ave, Jber, AK 99506-3702
	(907) 580-5556
	Not Available

Provider's Profile

Full Name	Brittany Kinsler
Gender	Female
Speciality	Clinical Nurse Specialist - Acute Care
Location	5955 Zeamer Ave, Jber, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1992428288
Provider Enumeration Date: 09/21/2022
Last Update Date: 09/21/2022

Medical Identifiers

Medical identifiers for Brittany Kinsler such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1992428288	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
364SA2100X	Clinical Nurse Specialist - Acute Care	30615 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brittany Kinsler is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Brittany Kinsler, CNS 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-5556	Brittany Kinsler, CNS 5955 Zeamer Ave, Jber, AK 99506-3702 Ph: (907) 580-5556

News Archive

FDA clears iCAD's VeraLook computer-aided detection product for virtual colonoscopy

The U.S. Food and Drug Administration has given clearance to VeraLook™, iCAD's computer-aided detection product used in the interpretation of virtual colonoscopy exams. iCAD is an industry-leading provider of advanced image analysis solutions for the early detection of cancer.

Chikungunya, dengue, and Zika viruses: three viruses in one mosquito

The study published in Nature Communications on May 19 found that Aedes aegypti, the primary mosquito that carries the Zika virus, might also transmit chikungunya and dengue viruses with one bite.

Neurotransmitter glutamate plays role in alcohol cravings, IU-led study finds

A study led by Indiana University on neurochemical changes associated with alcohol addiction found that the neurotransmitter glutamate plays a role in some alcohol cravings.

Pitt-led researchers awarded NIH grant to improve risk assessment of cerebral aneurysms

Although cerebral aneurysms affect a substantial portion of the adult population, the risk of treatment including open brain surgery often outweighs the risks associated with rupture.

Once a year treatment for osteoporosis now available in the U.S.

A once-a-year treatment for the bone-thinning disease osteoporosis has been given approval by the Food and Drug Administration (FDA) in the United States.

Brittany Kinsler, CNS - Clinical Nurse Specialist in Jber, AK